Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam

Medicina

Volumn 63, Issue 3, 2003, Pages 211-214

  Casellas, Jose M ^a   Visser, Matias ^a   Macdougall, Natalia ^a   Tome, Gabriela ^a   Sabban, Hugo Cohen ^b   Soutric, Jorge ^c   Arenoso, Hector ^c   Botelho, René ^d   De la Vega, Roxana ^d   Carvajal, Lidia ^e   Culasso, Catalina ^e   del Carmen Espínola, María ^f   García, Patricia ^g   Guerra, Humberto ^h   Ingaramo, Damian ⁱ   Scappini, Juan Pablo ⁱ   Pedreira, Walter ^j   Sader, Helio ^k   Reis, Adriana ^k   Zurita, Jeannete ^l  

^a Centro Estudios en Antimicrobianos   (Argentina)

^b Hospital Manuel Belgrano   (Argentina)

^c Laboratorios Bago   (Argentina)

^d Hosp Clin   (Bolivia)

^e Hospital de Ninos de Cordoba   (Argentina)

^f Hospital Militar Central   (Paraguay)

^g Universidad Nacional   (Chile)

^h UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

ⁱ IDIMYC   (Argentina)

^j Universidad Nacional   (Uruguay)

^k FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^l Universidad Nacional   (Ecuador)

more..

Author keywords

Amoxicillin sulbactam (875 125mg); Escherichia coli; Urine inhibitory titers

Indexed keywords

AMOXICILLIN; SULBACTAM; TRIFAMOX;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL LABORATORY; CONTROLLED STUDY; DRUG URINE LEVEL; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; SOUTH AMERICA; URINE;

ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; SULBACTAM; URINARY TRACT INFECTIONS; URINE;

EID: 0038298039     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Casellas JM, Visser M, Tomé G, Cohen H, Soutric J, Arenoso H. Erradicación de Escherichia coli de la orina vesical por amoxicilina-sulbactam. Actividad intrínseca del inhibidor. Enferm Infecc Microbiol Clin 2001; 19: 206-10.
2. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557.
3. Casellas JM, Visser M, Coco B, et al. South American collaborative study on the etiology of community-acquired lower urinary tract infections and the activity of amoxicillin, amoxicillin-sulbactam and sulbactam. Revista Chilena de Infectología. In press 2002.
4. National Committee for Clinical Laboratory Standards. 22: M2-A7. 2002. In: NCCLS, Wayne PE, U.S.A..
5. Casellas JM, Arenoso HJ, Soutric JL, Tomé G, Goldberg M. Estudio comparativo in vitro e in vivo de 3 asociaciones de inhibidores suicidas de beta-lactamasas con aminopenicilinas. Rev Esp Quimioterap 1993; 6: 289-97.
6. Klasen M, Edberg S. Measurement of antibiotics in human body fluids: Techniques and significance. In: Lorian V. Antibiotics in laboratory medicine. 4th Ed. Baltimore: Williams & Wilkins. USA. 1996; p 230-295.
7. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infec Dis 1998; 26: 1-10.
8. Bantar C, Nicola F, Fernandez Canigia L, et al. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections. Journal of Chemotherapy 2000; 12: 223-7.
9. National Committee for Clinical Laboratory Standards. 22: M100-S12; 2002. In: NCCLS, Wayne PE, U.S.A
10. Casellas JM, Guzmán Blanco M, Pinto ME The sleeping giant. Antimicrobial resistance. Infect Dis Clin North America 1994; 8: 29-45.
11. Guzmán Blanco M, Casellas JM, Sader HS. Bacterial resistance to antimicrobial agents in Latin America: The giant is awakening. Infect Dis Clin North America 2000; 14: 67-81.
12. Bantar C, Nicola F, Arenoso J, et al. Pharmacokinetic and pharmacodynamics of amoxicillin-sulbactam, a novel aminopenicillin-β-lactamase inhibitor combination, against Escherichia coli. Antimicrob Agents Chemother 1999; 43: 1503-4.
13. Alonso S, Farinati A, Thoroughgood V, Goldberg M, Piccinalli L, Casellas JM. Amoxicilina-sulbactam en infecciones urinarias bajas de la mujer. Ginecol Reprod 1990; 2: 27-35.
14. Sánchez Velazco H, Biganni L, Delgado E. Tratamiento de la infección urinaria baja aguda de la mujer con monodosis de amoxicilina-sulbactam. Prensa Med Argent 1990; 7; 77: 44-7.
15. López CR, Contos J. Tratamiento de un día con amoxicilina-sulbactam (infección urinaria baja aguda de la mujer). Prensa Med Argent 1992; 79: 17-20.
16. Winberg J, Herthelius-Elman M, Mollby R and Nord CE. Pathogenesis of urinary tract infections: experimental studies of vaginal resistance to colonization. Pediatr Nephrol 1993; 7: 509-14
17. Farinati A, Ortega Soler C, Gambaro E, Mormandi JO, Tilli M, Caruso N. Uso de la combinación amoxicilina-sulbactama en infecciones ginecoobstétricas. Congresso Internacional de Infectologia em Ginecologia e Obstetrícia, Nov 2000, Rio de Janeiro, Brasil. DST - J Bras Doencas Sex Transm 2000; 12: 42.
18. Exeni R, Casellas JM, Grimoldi I, et al. Efectividad de amoxicilina-sulbactama en el tratamiento de infecciones urinarias. 28° Congreso Argentino de Pediatría, 1988, Buenos Aires, Argentina. En Actas: p 199.